Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission We ...
Generally, the randomization for phase II trials is between two regimens, tumor response is the end point of interest, and the goal is to determine whether one experimental regimen should be brought ...
Two text message or phone reminders were more effective in reducing missed primary care appointments than a single reminder, particularly in patients at high risk of missing appointments. Objectives: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results